financetom
Business
financetom
/
Business
/
Tata-Mistry verdict: How will it impact corporate governance standards in India? Experts weigh in
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata-Mistry verdict: How will it impact corporate governance standards in India? Experts weigh in
Mar 26, 2021 10:28 AM

It is a big win for Tata Sons in the legal battle against Cyrus Mistry. The Supreme Court in its judgment has allowed the appeal of Tata Sons and dismissed the plea filed by the Pallonji Group.

This means the NCLAT judgment of 2019, which had restored Cyrus Mistry as the executive chairman of the conglomerate, has been set aside.

The apex court has also said that it can't adjudicate on fair compensation to Pallonji Group for their shareholding. Both parties can decide between themselves under the provisions of Article 75 of the Articles of Association.

For context, the Pallonji Group has been in talks with lenders for a debt recast and has been pushing to sell its 18.37 percent stake in Tata Sons. Article 75 gives Tata Sons the right to first refusal.

To discuss the victory for Tata’s and what this means as far as the precedence for corporate governance standards for the country, CNBC-TV18 spoke to Shriram Subramanian, MD of InGovern; Ketan Dalal, MD of Katalyst Advisors; and Cherag Balsara, advocate at Bombay High Court.

They also spoke about the terms of the separation, the role of Article 75 and the various technicalities on that, and the options available for Tata Group to pay back the Mistry’s and relieve them of 18 percent shareholding in Tata Group.

Watch this video for more.

(Edited by : Bivekananda Biswas)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teekay Launches $40 Million Buyback Program
Teekay Launches $40 Million Buyback Program
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- Teekay ( TK ) said Monday that its board has authorized a new share buyback program for the repurchase of up to $40 million common stock. The shipping company said it has nearly completed a previous $25 million repurchase program initiated in August 2022, buying back about 3.3 million shares at an average...
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Sep 9, 2024
Sunday, Summit Therapeutics Inc. ( SMMT ) released data from the primary analysis of the Phase 3 HARMONi-2 trial of ivonescimab conducted in China, sponsored by collaboration partner Akeso, Inc. The data was presented at the International Association for the Study of Lung Cancer’s 2024 World Conference on Lung Cancer. The trial evaluated monotherapy ivonescimab against monotherapy Merck ( MRK...
Top Premarket Gainers
Top Premarket Gainers
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- Intelligent Bio Solutions ( INBS ) shares surged more than 68% pre-bell Monday, extending Friday's rally. Summit Therapeutics ( SMMT ) shares advanced more than 31% after the company reported that a phase 3 trial of ivonescimab demonstrated significantly improved progression-free survival in patients with non-small cell lung cancer. Terns Pharmaceuticals ( TERN...
Top Premarket Decliners
Top Premarket Decliners
Sep 9, 2024
07:56 AM EDT, 09/09/2024 (MT Newswires) -- Wheeler REIT (WHLR) shares slumped 23% pre-bell Monday, paring Friday's rally. C4 Therapeutics ( CCCC ) shares dropped 17%, adding to a 7.4% loss in the previous session. SmartKem ( SMTK ) shares were down 11%, reversing from Friday's gains. Price: 7.89, Change: -2.36, Percent Change: -23.02 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved